NTRP
NextTrip IncNASDAQCONSUMER CYCLICALTRAVEL SERVICES
Key Statistics
Market Cap
$47.96M
P/E Ratio
—
EPS
$-2.28
Beta
3.34
52W High
$5.20
52W Low
$1.50
50-Day MA
$2.97
200-Day MA
$3.55
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About NextTrip Inc
Neurotrope, Inc., a biopharmaceutical company, is focused on developing a product platform for the treatment of Alzheimer's disease. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $2.18M |
| Gross Profit (TTM) | 413,120 |
| EBITDA | $-12.27M |
| Operating Margin | -257.00% |
| Return on Equity | -681.00% |
| Return on Assets | -84.70% |
| Revenue/Share (TTM) | $0.30 |
| Book Value | $0.47 |
| Price-to-Book | 8.07 |
| Price-to-Sales (TTM) | 22.00 |
| EV/Revenue | 22.55 |
| EV/EBITDA | -0.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1508.00% |
| Shares Outstanding | $13.57M |
| Float | $6.29M |
| % Insiders | 31.39% |
| % Institutions | 8.18% |
Analyst Ratings
Consensus ($7.83 target)
1
BuyData last updated: 4/9/2026